e-learning
resources
ERS Research Seminars
2012
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of CF ion transport defect in airway inflammation and implication for antiinflammatory therapies
M. Mall (Heidelberg, Germany)
Source:
Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Number:
14
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Mall (Heidelberg, Germany). Role of CF ion transport defect in airway inflammation and implication for antiinflammatory therapies. Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Role of altered immune response in CF and implication for antiinflammatory therapies
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012
Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties
via
hydration
Source: Eur Respir J, 59 (2) 2100185; 10.1183/13993003.00185-2021
Year: 2022
Pharmacological treatment of the biochemical defect in cystic fibrosis airways
Source: Eur Respir J 2001; 17: 1314-1321
Year: 2001
Allergic airway inflammation induces a pro-secretory epithelial ion transport phenotype in mice
Source: Eur Respir J 2010; 36: 1436-1447
Year: 2010
Potential therapeutic use of 12-Lipoxygenase inhibitors in the treatment of mucus overproduction in cystic fibrosis
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009
The GPx1-PTP1B-PP2A axis: A key determinant of airway inflammation and alveolar destruction
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Year: 2013
Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies
Source: Eur Respir J 2017; 49(1): 1600903; DOI: 10.1183/13993003.00903-2016
Year: 2017
Targeting airway inflammation in asthma: current and future therapies
Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies
Year: 2009
Targeting airway inflammation in asthma: current and future therapies
Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment
Year: 2009
A crucial role for lung interstitial macrophages in preventing airway allergy
Source: Annual Congress 2009 - Infections, immunity and inflammation
Year: 2009
A potential role of P2X
7
R in allergic airway inflammation
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
Role of airway smooth muscles in chronic airway inflammation and lung fibrosis and possible therapeutic potential of endothelin receptor antagonism
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010
ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapies
Source: Eur Respir J, 56 (6) 2000946; 10.1183/13993003.00946-2020
Year: 2020
Lack of therapeutic potential for topical metformin in treatment of airway secretion dehydration in cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009
The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model
Source: Eur Respir J, 52 (6) 1801133; 10.1183/13993003.01133-2018
Year: 2018
Cross-talk of inflammatory mediators and airway epithelium reveals the cystic fibrosis transmembrane conductance regulator as a major target
Source: ERJ Open Res, 7 (4) 00247-2021; 10.1183/23120541.00247-2021
Year: 2021
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy
Source: Eur Respir J 2014; 43: 1211-1212
Year: 2014
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy
Source: Eur Respir J 2013; 42: 350-361
Year: 2013
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy
Source: Eur Respir J 2014; 43: 1208-1211
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept